Co-Payments for Expensive Drugs Soar – New York Times
Perhaps this should be viewed as a good thing for the prospects of true systemic health reform, given of course you personally don’t die of cancer or become disabled by MS because you can’t afford the drugs to treat the illness. When the middle class begins to feel the bite of this kind of profit before people policies forced upon them, perhaps they’ll be a real, broad-based coalition for reform. Insurers and drug companies may have just gotten a little too greedy and I don’t think Montel Williams’ TV commercials will save them.
Jonathan Cohn has the same idea
Ezra wonks out on tier 4 drugs
